Cargando…
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma
BACKGROUND: Immune responses against tumors are subject to negative feedback regulation. Immune checkpoint inhibitors (ICIs) blocking Programmed cell death protein 1 (PD-1), a receptor expressed on T cells, or its ligand PD-L1 have significantly improved the treatment of cancer, in particular malign...
Autores principales: | Martins Nascentes Melo, Luiza, Herrera-Rios, Dayana, Hinze, Daniel, Löffek, Stefanie, Oezel, Irem, Turiello, Roberta, Klein, Juliane, Leonardelli, Sonia, Westedt, Isa-Vanessa, Al-Matary, Yahya, Egea-Rodriguez, Sara, Brenzel, Alexandra, Bau, Maja, Sucker, Antje, Hadaschik, Eva, Wirsdörfer, Florian, Hanenberg, Helmut, Uhlenbrock, Niklas, Rauh, Daniel, Poźniak, Joanna, Rambow, Florian, Marine, Jean-Christophe, Effern, Maike, Glodde, Nicole, Schadendorf, Dirk, Jablonska, Jadwiga, Hölzel, Michael, Helfrich, Iris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083881/ https://www.ncbi.nlm.nih.gov/pubmed/37028818 http://dx.doi.org/10.1136/jitc-2021-004150 |
Ejemplares similares
-
CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor models
por: Effern, Maike, et al.
Publicado: (2022) -
CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma
por: Löffek, Stefanie, et al.
Publicado: (2015) -
From Tpex to Tex: a journey through CD8(+) T cell responses in cancer immunotherapy
por: Messmer, Julia M., et al.
Publicado: (2023) -
Tension in Cancer
por: Löffek, Stefanie, et al.
Publicado: (2016) -
NF1 mutations in conjunctival melanoma
por: Scholz, S. L., et al.
Publicado: (2018)